| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |